AVITA Medical (RCEL) Free Cash Flow (QoQ) (2019 - 2025)
AVITA Medical (RCEL) Free Cash Flow (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.80 Bn | 176.50 Bn | 6.27 Bn |
| 2 | Stryker | 128.84 Bn | 125.96 Bn | 3.81 Bn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.51 Bn | 67.06 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.18 Bn | 44.51 Bn | 1.29 Bn |
| 6 | Dexcom | 28.40 Bn | 27.28 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.16 Bn | 25.88 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 24.66 Bn | 21.54 Bn | 2.07 Bn |
| 10 | AVITA Medical | 133.18 Mn | 116.83 Mn | 14.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.65% |
| Sep 30, 2025 | 47.06% |
| Jun 30, 2025 | 2.17% |
| Mar 31, 2025 | -35.19% |
| Dec 31, 2024 | -7.01% |
| Sep 30, 2024 | 39.22% |
| Jun 30, 2024 | 45.60% |
| Mar 31, 2024 | -97.25% |
| Dec 31, 2023 | -17.76% |
| Sep 30, 2023 | 2.15% |
| Jun 30, 2023 | -6.73% |
| Mar 31, 2023 | -214.76% |
| Sep 30, 2021 | -10.64% |
| Jun 30, 2021 | -38.45% |
| Mar 31, 2021 | -61.46% |
| Dec 31, 2020 | 29.10% |
| Mar 31, 2020 | -57.98% |
| Dec 31, 2019 | 5.35% |